Outcomes of gefitinib therapy for disease recurrence in medically inoperable stage I lung adenocarcinoma patients with active EGFR mutations receiving stereotactic body radiotherapy: a single-institute retrospective study
Kosuke Kashiwabara,
Hiroshi Semba,
Shinji Fujii,
Shinsuke Tsumura
